Open research questions in Respiratory viral infections research
1,098 gap statements mined from Respiratory viral infections research papers in our 7.9M-paper local library, which holds 3,524 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.
Choosing where to publish on Respiratory viral infections research? See the ranked Medicine journals.
What the literature leaves open
Atypical bacteria are intracellular pathogens that cannot be diagnosed by standard bacterial culture. The study required the use of specific laboratory diagnostic modalities and antibiotics. There was a need to evaluate the effectiveness of empirical treatment with clarithromycin for atypical pneumonia.
Implications of empirical testing and treatment for atypical bacteria in patients hospitalized with COVID, influenza, or RSV: a retrospective observational cohort study · 2026 · DOIThe study references the challenge of managing RSV infections due to the lack of effective RSV-specific antivirals.
Epidemiology and seasonality of respiratory syncytial virus among hospitalized pediatric patients with lower respiratory tract infections in Negeri Sembilan, Malaysia (2017–2024) · 2026 · DOIThere is a need for continuous surveillance and the development of targeted management strategies for RSV infections. The study identifies a gap in understanding the seasonality and exogenous factors influencing RSV cases in tropical settings.
Epidemiology and seasonality of respiratory syncytial virus among hospitalized pediatric patients with lower respiratory tract infections in Negeri Sembilan, Malaysia (2017–2024) · 2026 · DOIThe study of RSV infection is challenging due to the complexity of the airway mucus gel layer. The role of MUC5B in RSV infection is difficult to understand due to the limited knowledge of its function. The development of effective treatments for RSV infection is challenging due to the lack of understanding of the underlying mechanisms.
MUC5B Expression Is Associated with Reduced Respiratory Syncytial Virus Infection and Pulmonary Inflammation · 2026 · DOICurrent methods for detecting respiratory pathogens have limitations, such as requiring extensive pretreatment steps. There is a need for innovative diagnostic tools to address the urgent healthcare burden of lung diseases. The development of new biosensor technologies is crucial for improving the detection of respiratory pathogens.
Detecting Respiratory Pathogens for Diagnosing Lower Respiratory Tract Infections at the Point of Care: Challenges and Opportunities · 2025 · DOICurrent detection methods have limitations in terms of detection time. Susceptibility to nucleic acid contamination is a significant challenge. There is a need for a faster and more reliable detection method.
LAMP-Based 4-Channel Microfluidic Chip for POCT Detection of Influenza A H1N1, H3N2, and Influenza B Victoria Viruses · 2025 · DOISince all samples included in this study were obtained from SARI cases, it is still uncertain whether there is an association between the severity of HMPV infection and specific genotypes, particularly given our lack of standardized clinical severity assessment.
Epidemiology and Genetic Diversity of Human Metapneumovirus in Patients with Severe Acute Respiratory Infection from 2023 to 2024 in Ningxia, China · 2025 · DOIThe association between COPD exacerbation and RSV infection is not well studied. There is a lack of data on the impact of RSV infection on COPD patients.
Prevalence of Respiratory Syncytial Virus Infection in Hospitalized COPD Patients in Spain Between 2018–2022 · 2025 · DOIThe study highlights the need for continuous epidemiological surveillance and understanding of the factors associated with the severity of these infections. The study notes that the etiological heterogeneity of the syndrome poses a constant challenge to clinical practice and public health.
Risk of Incidence and Lethality by Etiology of Severe Acute Respiratory Syndrome in Hospitalized Children Under 1 Year of Age in Brazil in 2024: A Cross-Sectional Study · 2025 · DOIThere is a need for ongoing surveillance to understand the epidemiology of respiratory viruses. The circulation of respiratory viruses has shifted since the emergence of COVID-19. There is a lack of understanding of the age-specific detection of respiratory viruses.
Seasonal Pattern and Age-Specific Detection of Eight Respiratory Viruses Causing Acute Respiratory Infection in 2024, Bangkok, Thailand · 2025 · DOIThe lack of understanding of the immunological characteristics exhibited by infants and young children. The need for a predictive model to identify severe cases of RSV infection.
Analysis of the Specific Expression Profile of Immune Cells in Infants and Young Children Infected with RSV and Construction of a Disease Prediction Model · 2025 · DOIThere is a need to evaluate the effectiveness of nirsevimab in preventing hospitalisations for confirmed RSV infection. The impact of a strategy of immunisation at birth on the prevention of RSV-related hospitalisations is not well understood.
Effectiveness of Nirsevimab Immunoprophylaxis Administered at Birth to Prevent Infant Hospitalisation for Respiratory Syncytial Virus Infection: A Population-Based Cohort Study · 2024 · DOIBackgroundThe relationship between recent viral infection and subsequent susceptibility to, or protection against, other viruses remains unclear, particularly across age groups and symptom status.
Interactions between respiratory viruses in US adults and children: a prospective cohort study · 2026 · DOIHowever, the host factors governing viral entry still remain poorly understood.
Blocking two host receptors is better than one: Insights from RSV infection in human respiratory organoids · 2026 · DOIPost-COVID-19 changes in respiratory viral circulation may influence febrile seizures (FS) presentation, but associations between viral detection, co-detection and outcomes remain unclear.
Association of respiratory viral detection with complex febrile seizures and hospitalisation in children after the COVID-19 pandemic: a retrospective observational study · 2026 · DOIHuman adenoviruses (HAdV) circulate globally, but their seasonal patterns remain poorly defined.
Global Epidemiology of Human Adenoviruses, 2016–2024: A Pre‐ and Post‐COVID‐19 Analysis of Circulation Patterns and Epidemic Timing · 2026 · DOIQuantifying the burden of respiratory syncytial virus (RSV) in adults is challenging compared to influenza, and data among older adults remain scarce in Japan.
Incidence of RSV‐ and Influenza‐Associated Hospitalizations With Community‐Acquired Pneumonia and Other Acute Respiratory Infection Among Adults in Japan in 2022–2024: APSG‐J2 Study · 2026 · DOIUnderstanding hospitalisation burden of respiratory syncytial virus (RSV)-associated acute respiratory infection (ARI) in adults is crucial for informing immunisation policy, yet such data are lacking in most high-income countries.
Country‐Level RSV‐Related Hospitalisation Rates Among Adults in High‐Income Countries From an Ensemble Model Based on Direct Viral Testing Incidence Data · 2026 · DOIAlthough studies suggest it causes around 10% of respiratory hospitalizations in the United States, national and local data remain scarce.
Characteristics and Risk Factors Associated With Hospitalization and Severe Disease in Patients Aged ≥ 60 Years With Human Metapneumovirus Infection Over Three Consecutive Seasons (2021–2024) in Valladolid, Spain. The VALLAVIRUS Study · 2026 · DOIMost existing prediction models do not distinguish between colonizing bacteria and true pathogens. This leads to overestimation of infection risk and inappropriate antibiotic decision-making.
Predictors of secondary streptococcus pneumoniae and/or haemophilus influenzae infection in children hospitalised with RSV, and development of a clinical prediction model to inform antibiotic decisions: a retrospective cohort study based on coloniser–pathogen distinction · 2026 · DOIExisting syndromic surveillance tools, including the WHO Severe Acute Respiratory Infection definition, demonstrate limited diagnostic accuracy in children whose symptom profiles vary widely.
Enhancing respiratory virus surveillance among hospitalised children: a machine learning-based predictive model · 2026 · DOINo sample size calculation was performed before initiating the study, - The study was a retrospective observational cohort study, - The study was limited to patients admitted to a hospital in the Central Denmark…
Implications of empirical testing and treatment for atypical bacteria in patients hospitalized with COVID, influenza, or RSV: a retrospective observational cohort study · 2026 · DOICreating innovative diagnostic tools to address the urgent healthcare burden of lung diseases - Developing new biosensor technologies tailored for detecting respiratory pathogens in lower respiratory specimens - Strategies for detecting specific resistance mechanisms may be more relevant in some…
Detecting Respiratory Pathogens for Diagnosing Lower Respiratory Tract Infections at the Point of Care: Challenges and Opportunities · 2025 · DOIFurther research is needed to validate the hypothesis of the association between HMPV coinfection and intensive care unit (ICU) admission rates or disease severity, - Future studies could employ larger sample cohorts and longread sequencing technologies to further investigate potential recombination mechanisms in HMPV, - Validate whether glycosylation sites are located in functional antigenic domains through…
Epidemiology and Genetic Diversity of Human Metapneumovirus in Patients with Severe Acute Respiratory Infection from 2023 to 2024 in Ningxia, China · 2025 · DOIFurther research on virus transmissibility - Further research on the impact of humidity and environmental…
Most-cited papers in Respiratory viral infections research
- Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome · New England Journal of Medicine · 2003 · 3,708 citations
- Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States · JAMA · 2003 · 2,998 citations
- Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis · The Lancet · 2010 · 2,405 citations
- Coronavirus as a possible cause of severe acute respiratory syndrome · The Lancet · 2003 · 2,346 citations
- Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study · The Lancet · 2017 · 2,190 citations
- Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults · New England Journal of Medicine · 2005 · 1,987 citations
- The Burden of Respiratory Syncytial Virus Infection in Young Children · New England Journal of Medicine · 2009 · 1,946 citations
- Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants · PEDIATRICS · 1998 · 1,807 citations
- Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis · The Lancet · 2022 · 1,737 citations
- A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong · New England Journal of Medicine · 2003 · 1,704 citations
Most recent work
- Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational study · The Lancet Infectious Diseases · 2026
- IDSA 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza, and RSV Infections in Immunocompromised Patients · Clinical Infectious Diseases · 2026
- Respiratory Virus Activity — United States, July 1, 2024–June 30, 2025 · MMWR Morbidity and Mortality Weekly Report · 2026
- Real-world emergence of nirsevimab resistance in breakthrough infections with respiratory syncytial virus-B: a multicentre observational study in France · The Lancet Microbe · 2026
- Effectiveness of nirsevimab immunisation after birth versus RSVpreF maternal vaccination in preventing RSV-related hospitalisations in infants: a population-based retrospective cohort study · The Lancet Child & Adolescent Health · 2026
- Risk of Cardiorespiratory Events Following Respiratory Syncytial Virus–Related Hospitalization · JAMA Network Open · 2026
- Bivalent RSVpreF effectiveness against RSV-associated hospital or emergency department care over two seasons: a retrospective test-negative case control study · The Lancet Regional Health - Americas · 2026
- Immunosenescence and susceptibility to respiratory viruses: a state-of-the-art review · European Respiratory Review · 2026
- Reduced Emergency Department Visits and Hospitalizations in Infants after Universal Respiratory Syncytial Virus Immunization, Italy, 2024–25 · Emerging infectious diseases · 2026
- Interim Safety of RSVpreF Vaccination During Pregnancy · JAMA · 2026
Find a gap in your own Respiratory viral infections research sub-topic
This page shows what the Respiratory viral infections research literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 7.9M-paper local library and writes the gaps from its rows.
Open the Research Gap Finder →